Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93H32 | — |
dose of Kinrix to a patient who is 6 months old; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number 93H32, expiry date 19-OCT-2026) for prophylaxis. On 28-JAN-2026, the patient received Kinrix. On 28-JAN-2026, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: dose of Kinrix to a patient who is 6 months old). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-JAN-2026 Practice administrator called to report that they administered yesterday on 28-JAN-2026 a dose of Kinrix to a patient who was 6 months old. The patient was supposed to receive it individually.